{"id":"W4318710361","doi":"10.2196/41197","title":"Repeat Ivermectin Mass Drug Administrations for Malaria Control II: Protocol for a Double-blind, Cluster-Randomized, Placebo-Controlled Trial for the Integrated Control of Malaria","year":2023,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Malaria Research and Control","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Malaria; Ivermectin; Mass drug administration; Placebo; Medicine; Cluster (spacecraft); Drug; Cluster randomised controlled trial; Double blind; Randomized controlled trial; Pharmacology; Population; Alternative medicine; Internal medicine; Environmental health; Immunology; Veterinary medicine; Computer science; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.02825998,0.0006632935,0.002823194,0.0009996995,0.001536047,0.0004402413,0.001126994,0.000543909,0.0003904675],"category_scores_gemma":[0.01739185,0.0004068035,0.001948301,0.001250961,0.0007920398,0.000270005,0.0001570249,0.001337411,0.00002578571],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00026522,"about_ca_system_score_gemma":0.004173039,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00007328617,"about_ca_topic_score_gemma":0.0001002615,"domain_scores_codex":[0.9897681,0.002410694,0.00239624,0.001182255,0.002034991,0.002207692],"domain_scores_gemma":[0.9669474,0.02537772,0.0007907964,0.001452209,0.004807358,0.0006245137],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9329596,0.001719111,0.00001003224,0.001936424,0.00167006,0.00001293799,0.000184741,0.00005421853,0.003687935,0.02307757,0.03404095,0.0006464559],"study_design_scores_gemma":[0.83098,0.01377409,0.00001057954,0.0008471676,0.0002465969,0.000007468244,0.0002925027,0.07718454,0.001330613,0.002266971,0.07275183,0.0003076691],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.0000766021,0.000003309132,0.04117375,0.03471547,0.00005933578,0.9225768,0.0006912567,0.0002230762,0.0004803417],"genre_scores_gemma":[0.02375217,5.520798e-7,0.001040942,0.0001713817,0.001243573,0.9567007,0.0001798838,0.0001562299,0.0167546],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.1019796,"threshold_uncertainty_score":0.9998384,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1803567257033983,"score_gpt":0.5158947357512614,"score_spread":0.3355380100478632,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}